KollelBudget may earn a commission from purchases made via the links on this website, read our disclosure policy here. Thank you for your support!

 

Home > Uncategorized > Kleenex Anti-Viral Facial Tissues, 18 Cube Boxes, 60 Tissues per Box (1,080 Tissues Total) Only $9.39 – $11.08 + Free Shipping With Subscribe & Save From Amazon!

Kleenex Anti-Viral Facial Tissues, 18 Cube Boxes, 60 Tissues per Box (1,080 Tissues Total) Only $9.39 – $11.08 + Free Shipping With Subscribe & Save From Amazon!

January 1, 2020 Comments Off on Kleenex Anti-Viral Facial Tissues, 18 Cube Boxes, 60 Tissues per Box (1,080 Tissues Total) Only $9.39 – $11.08 + Free Shipping With Subscribe & Save From Amazon!

UPDATE: Dead!

Amazon has the Kleenex Anti-Viral Facial Tissues, 18 Cube Boxes, 60 Tissues per Box (1,080 Tissues Total) marked down to $16.93, use “Subscribe & Save” to get free shipping and bring the price down to only $16.08. Plus clip the $5 coupon that is on the product page to bring the price down to only $11.08!

If you have 5 or more “Subscribe & Save” subscriptions a month you will save 15% instead of 5% and your total will be only $9.39 + Free shipping!

  • Contains 18 cube boxes, 60 Kleenex Anti-Viral tissues per box (1,080 tissues total)
  • Kills 99.9% of cold & flu viruses
  • Durable, 3-ply tissues made with thick, soft plies
  • Tissue boxes available in a variety of colors, designs, and sizes (may vary from image shown)
  • Prepare better for allergy, cold & flu, & back to school seasons with Kleenex
  • Buy in bulk & save on America’s #1 facial tissue brand* (among national brands)

Kleenex Anti-Viral Facial Tissues, 18 Cube Boxes, 60 Tissues per Box (1,080 Tissues Total)

 

Note: The price is accurate as of the time of posting, but Amazon’s prices are always changing, so make sure to check the price shown on Amazon when you are checking out, as that will be the price you are charged!

After your order processes you can to go to “Your Account” and click on “Manage Subscribe & Save” to cancel any future shipments

Comments are closed.